Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	56.63	56.63	34,155	32.26	25.38	17.99
Revenue Growth (YoY)	65.81%	-99.83%	105767.55%	27.11%	41.05%	137.76%
Cost of Revenue	30.99	31.65	17,561	17.47	13.51	10.02
Gross Profit	25.63	24.98	16,594	14.8	11.87	7.98
Selling, General & Admin	7.31	7.31	5,122	4.48	3.34	3.41
Research & Development	6.88	6.88	6,200	4.05	5.11	5.53
Other Operating Expenses	-5.4	-5.74	1,596	1.19	1.31	1.32
Operating Expenses	14.84	14.19	12,918	9.72	9.76	10.26
Operating Income	10.79	10.79	2,025	5.07	2.1	-2.29
Interest Income	0.02	0.02	7.45	0	0	0.01
Interest Expense	0.59	0.59	-1,112.71	0.19	0.26	0.36
Other Expense / Income	9.76	9.76	-840.6	-2.28	-2.3	-0.39
Pretax Income	0.46	0.46	3,986	6.3	4.14	-2.24
Income Tax	-19.65	-19.65	-424.03	-1.74	-0.94	0
Net Income	20.11	20.11	4,410	8.9	5.09	-2.24
Net Income Growth	464.56%	-99.54%	49459.23%	74.87%	-	-
Shares Outstanding (Basic)	1,021	1,015	1,013	1,011	943	832
Shares Outstanding (Diluted)	1,042	1,023	1,013	1,011	943	832
Shares Change	2.81%	1.02%	0.23%	7.17%	13.30%	1.96%
EPS (Basic)	0.02	0.02	4.35	0.01	0.01	-0.00
EPS (Diluted)	0.02	0.02	4.35	0.01	0.01	-0.00
EPS Growth	460.00%	-99.55%	58683.78%	37.04%	-	-
Free Cash Flow	-4.1	-4.09	-2.4	6.01	2.86	-1.83
Free Cash Flow Per Share	-0.00	-0.00	-0.00	0.01	0.00	-0.00
Gross Margin	45.27%	44.11%	48.58%	45.86%	46.76%	44.34%
Operating Margin	19.05%	19.05%	5.93%	15.72%	8.29%	-12.70%
Profit Margin	35.51%	35.51%	12.91%	27.58%	20.05%	-12.45%
Free Cash Flow Margin	-7.25%	-7.23%	-0.01%	18.63%	11.28%	-10.16%
Effective Tax Rate	-4242.25%	-4242.25%	-10.64%	-27.54%	-22.77%	-
EBITDA	12.33	12.32	3,289	6.51	3.63	-0.76
EBITDA Margin	21.78%	21.76%	9.63%	20.16%	14.30%	-4.24%
Depreciation & Amortization	1.53	1.53	1.34	1.43	1.52	1.51
EBIT	10.8	10.79	3,287	5.07	2.11	-2.27
EBIT Margin	19.07%	19.05%	9.62%	15.72%	8.29%	-12.63%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.